Skip to main content

Table 2 Comparison of study endpoints at 12 weeks by randomized treatment assignment

From: A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease

Characteristic

Calcium acetate

(N = 37)

Placebo

(N = 41)

P-value

Serum phosphorus (mg/dL)

n = 37

4.4 ± 1.2

n = 36

5.1 ± 1.4

0.04

Serum calcium, corrected (mg/dL)

n = 37

9.5 ± 0.8

n = 36

8.8 ± 0.8

< 0.001

Intact parathyroid hormone (pg/mL)

n = 35

150 ± 157

n = 38

351 ± 292

< 0.001

Serum bicarbonate (mEq/L)

n = 35

24.0 ± 3.7

n = 35

21.6 ± 3.8

0.008

Serum albumin (mg/dL)

n = 37

3.6 ± 0.5

n = 36

3.5 ± 0.5

0.34